Literature DB >> 31126806

Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review.

Ruth E Cooper1, Neelam Laxhman2, Nadia Crellin3, Joanna Moncrieff3, Stefan Priebe2.   

Abstract

Antipsychotics are the first-line treatment for people with schizophrenia or psychosis. There is evidence that they can reduce the symptoms of psychosis and risk of relapse. However many people do not respond to these drugs, or experience adverse effects and stop taking them. In the UK, clinical guidelines have stressed the need for research into psychosocial interventions without antipsychotics. This systematic review examines the effects of psychosocial interventions for people with schizophrenia or psychosis who are on no/minimal antipsychotics. Databases were searched for empirical studies investigating a psychosocial intervention in people with a schizophrenia spectrum disorder who were not taking antipsychotics or had received an antipsychotic minimisation strategy. We identified nine interventions tested in 17 studies (N = 2250), including eight randomised controlled trials. Outcomes were generally equal to or in a small number of cases better than the control group (antipsychotics/treatment as usual) for Cognitive Behavioural Therapy (CBT), Need Adapted Treatment and Soteria. The remaining interventions provided some encouraging, but overall inconsistent findings and were Psychosocial Outpatient Treatment, Open Dialogue, Psychosocial Inpatient Treatment, Psychoanalysis/Psychodynamic Psychotherapy, Major Role Therapy, and Milieu Treatment. Study quality was generally low with little recent research. In conclusion, nine psychosocial interventions have been studied for patients on no/minimal antipsychotics. The majority of studies reported outcomes for the intervention which were the same as the control group, however, study quality was problematic. Given the adverse effects of antipsychotics and that many people do not want to take them, high quality trials of psychosocial treatments for people on minimal/no antipsychotics are needed.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternative treatments; Minimal antipsychotics; Not taking antipsychotics; Psychological treatments; Schizophrenia

Mesh:

Substances:

Year:  2019        PMID: 31126806     DOI: 10.1016/j.schres.2019.05.020

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  12 in total

1.  Using Open Questions to Understand 650 People's Experiences With Antipsychotic Drugs.

Authors:  John Read; Ann Sacia
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

Review 2.  Fear of relapse in schizophrenia: a mixed-methods systematic review.

Authors:  Stephanie Allan; Andrew Gumley; Zofia Zukowska; Emily Eisner; Li Ling
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-02-13       Impact factor: 4.519

3.  Mental health professionals' views and experiences of antipsychotic reduction and discontinuation.

Authors:  Ruth E Cooper; Éanna Hanratty; Nicola Morant; Joanna Moncrieff
Journal:  PLoS One       Date:  2019-06-20       Impact factor: 3.240

4.  Service-user efforts to maintain their wellbeing during and after successful withdrawal from antipsychotic medication.

Authors:  Miriam Larsen-Barr; Fred Seymour
Journal:  Ther Adv Psychopharmacol       Date:  2021-01-31

5.  An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders.

Authors:  Nadia E Crellin; Stefan Priebe; Nicola Morant; Glyn Lewis; Nick Freemantle; Sonia Johnson; Rob Horne; Vanessa Pinfold; Lyn Kent; Ruth Smith; Katherine Darton; Ruth E Cooper; Maria Long; Jemima Thompson; Lisa Gruenwald; Robert Freudenthal; Jacki L Stansfeld; Joanna Moncrieff
Journal:  BMC Psychiatry       Date:  2022-03-15       Impact factor: 3.630

6.  Psychological Interventions for Young People With Psychotic Disorders: A Systematic Review.

Authors:  Vera Gergov; Branka Milic; Henriette Löffler-Stastka; Randi Ulberg; Eleni Vousoura; Stig Poulsen
Journal:  Front Psychiatry       Date:  2022-03-24       Impact factor: 5.435

7.  Non-pharmacological treatments for schizophrenia in Southeast Europe: An expert survey.

Authors:  Lidija Injac Stevović; Selman Repišti; Tamara Radojičić; Norman Sartorius; Sonila Tomori; Alma Džubur Kulenović; Ana Popova; Martina Rojnić Kuzman; Ilias I Vlachos; Shukrije Statovci; Alexei Bandati; Antoni Novotni; Stojan Bajraktarov; Anca-Livia Panfil; Nadja P Maric; Mirjana Delić; Nikolina Jovanović
Journal:  Int J Soc Psychiatry       Date:  2021-08-14

8.  From Wish to Reality: Soteria in Regular Care-Proof of Effectiveness of the Implementation of Soteria Elements in Acute Psychiatry.

Authors:  Theresa Wolf; Philine Fabel; Adrian Kraschewski; Maria C Jockers-Scherübl
Journal:  Front Psychiatry       Date:  2021-07-09       Impact factor: 4.157

9.  Developing a Theory-Informed Smartphone App for Early Psychosis: Learning Points From a Multidisciplinary Collaboration.

Authors:  Natalie Berry; Matthew Machin; John Ainsworth; Katherine Berry; Dawn Edge; Gillian Haddock; Shon Lewis; Rohan Morris; Sandra Bucci
Journal:  Front Psychiatry       Date:  2020-12-10       Impact factor: 4.157

Review 10.  [Cross-sectoral therapeutic concepts and innovative technologies: new opportunities for the treatment of patients with mental disorders].

Authors:  Dusan Hirjak; Ulrich Reininghaus; Urs Braun; Markus Sack; Heike Tost; Andreas Meyer-Lindenberg
Journal:  Nervenarzt       Date:  2021-03-05       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.